Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently ...
Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, s...
Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for&n...
AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...
Pharma major Lupin announced that it has received approval for its Clobazam Oral Suspension, 2.5 mg/mL from the United S...
Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Elidel®1 (pimecrolimus)...
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...
Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...
Cannabics Pharmaceuticals Inc., a world leader in personalized cannabinoid medicine focused on cancer and its side effec...
I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...
Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...
Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...
Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...
UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Science...
Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commerci...
Multiple myeloma patients from Australia will have world-first access to a new first-in-class drug developed to treat th...
TauRx, a leader in neurodegenerative disease research, announced that the US Food and Drug Administration (FDA) has gran...
